1.Effect of Harderian adenectomy on the statistical analyses of mouse brain imaging using positron emission tomography.
Minsoo KIM ; Sang Keun WOO ; Jung Woo YU ; Yong Jin LEE ; Kyeong Min KIM ; Joo Hyun KANG ; Kidong EOM ; Sang Soep NAHM
Journal of Veterinary Science 2014;15(1):157-161
Positron emission tomography (PET) using 2-deoxy-2-[18F] fluoro-D-glucose (FDG) as a radioactive tracer is a useful technique for in vivo brain imaging. However, the anatomical and physiological features of the Harderian gland limit the use of FDG-PET imaging in the mouse brain. The gland shows strong FDG uptake, which in turn results in distorted PET images of the frontal brain region. The purpose of this study was to determine if a simple surgical procedure to remove the Harderian gland prior to PET imaging of mouse brains could reduce or eliminate FDG uptake. Measurement of FDG uptake in unilaterally adenectomized mice showed that the radioactive signal emitted from the intact Harderian gland distorts frontal brain region images. Spatial parametric measurement analysis demonstrated that the presence of the Harderian gland could prevent accurate assessment of brain PET imaging. Bilateral Harderian adenectomy efficiently eliminated unwanted radioactive signal spillover into the frontal brain region beginning on postoperative Day 10. Harderian adenectomy did not cause any post-operative complications during the experimental period. These findings demonstrate the benefits of performing a Harderian adenectomy prior to PET imaging of mouse brains.
Animals
;
Brain/*metabolism/radionuclide imaging
;
Fluorodeoxyglucose F18/*diagnostic use
;
Frontal Lobe/metabolism/radionuclide imaging
;
Harderian Gland/metabolism/radionuclide imaging/*surgery
;
Mice
;
Mice, Inbred BALB C
;
Neuroimaging/standards/*veterinary
;
Positron-Emission Tomography/*veterinary
;
Radiopharmaceuticals/*diagnostic use
2.Primary Tumor Maximum Standardized Uptake Value Measured on 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Is a Prognostic Value for Survival in Bile Duct and Gallbladder Cancer.
Ji Yong LEE ; Hong Joo KIM ; Seo Hyung YIM ; Dong Suk SHIN ; Jung Hee YU ; Deok Yun JU ; Jung Ho PARK ; Dong Il PARK ; Yong Kyun CHO ; Chong Il SOHN ; Woo Kyu JEON ; Byung Ik KIM
The Korean Journal of Gastroenterology 2013;62(4):227-233
BACKGROUND/AIMS: Few studies have assessed the prognostic value of the primary tumor maximum standardized uptake value (SUVmax) measured by 2-[18F]-fluoro-2-deoxy-D-glucose PET-CT for patients with bile duct and gallbladder cancer. METHODS: A retrospective analysis of 61 patients with confirmed bile duct and gallbladder cancer who underwent FDG PET-CT in Kangbuk Samsung Medical Center (Seoul, Korea) from April 2008 to April 2011. Prognostic significance of SUVmax and other clinicopathological variables was assessed. RESULTS: Twenty-three patients were diagnosed as common bile duct cancer, 17 as hilar bile duct cancer, 12 as intrahepatic bile duct cancer, and nine as gallbladder cancer. In univariate analysis, diagnosis of intrahepatic cholangiocarcinoma and gallbladder cancer, mass forming type, poorly differentiated cell type, nonsurgical treatment, advanced American Joint Committee on Cancer (AJCC) staging and primary tumor SUVmax were significant predictors of poor overall survival. In multivariate analysis adjusted for age and sex, primary tumor SUVmax (hazard ratio [HR], 4.526; 95% CI, 1.813-11.299), advanced AJCC staging (HR, 4.843; 95% CI, 1.760-13.328), and nonsurgical treatment (HR, 6.029; 95% CI, 1.989-18.271) were independently associated with poor overall survival. CONCLUSIONS: Primary tumor SUVmax measured by FDG PET-CT is an independent and significant prognostic factor for overall survival in bile duct and gallbladder cancer.
Aged
;
Bile Duct Neoplasms/*diagnosis/mortality/radionuclide imaging
;
Cholangiocarcinoma/diagnosis/mortality/radionuclide imaging
;
Female
;
Fluorodeoxyglucose F18/diagnostic use/metabolism/standards
;
Gallbladder Neoplasms/*diagnosis/mortality/radionuclide imaging
;
Humans
;
Kaplan-Meier Estimate
;
Liver Neoplasms/diagnosis/mortality/radionuclide imaging
;
Male
;
Middle Aged
;
Neoplasm Staging
;
Positron-Emission Tomography/standards
;
Prognosis
;
Proportional Hazards Models
;
Radiopharmaceuticals/diagnostic use/metabolism/standards
;
Retrospective Studies
;
Tomography, X-Ray Computed/standards